Cargando…
Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer
BACKGROUND: Enolase is an essential enzyme in the process of glycolysis and has been implicated in cancer progression. Though dysregulation of ENOs has been reported in multiple cancers, their prognostic value and specific role in bladder cancer (BLCA) remain unclear. METHODS: Multiple databases wer...
Autores principales: | Huang, Zhengnan, Yan, Yilin, Wang, Tengjiao, Wang, Zeyi, Cai, Jinming, Cao, Xiangqian, Yang, Chenkai, Zhang, Fang, Wu, Gang, Shen, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281045/ https://www.ncbi.nlm.nih.gov/pubmed/35836227 http://dx.doi.org/10.1186/s12967-022-03509-1 |
Ejemplares similares
-
A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer
por: Wang, Zeyi, et al.
Publicado: (2023) -
TEAD4 as a Prognostic Marker Promotes Cell Migration and Invasion of Urinary Bladder Cancer via EMT
por: Huang, Zhengnan, et al.
Publicado: (2021) -
Pyroptosis-Related Patterns Predict Tumor Immune Landscape and Immunotherapy Response in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2022) -
Establishment of an optimized orthotopic bladder cancer model in mice
por: Cai, Jinming, et al.
Publicado: (2022) -
A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2021)